Back to results
US 10,744,194 B2Granted
Zika virus purification
AssigneeValneva Austria GmbH
InventorsJana Barbero Calzado, Mario Nebenführ, Robert Schlegl, Michael Weber, Jürgen Wruss
Life of this patent
Estimating the term…
Abstract
Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.
Claims20
A process for purifying infectious Zika virus particles, wherein said process comprises the steps of:
- (i) providing a crude harvest (a) comprising infectious Zika virus particles, non-infectious Zika virus particles, and impurities, wherein the impurities are generated from growing Zika virus particles on a cell substrate;
- (ii) contacting said crude harvest (a) with an agent comprising protamine to obtain a Zika virus preparation (b) comprising infectious Zika particles, wherein said agent facilitates separation of infectious Zika particles from non-infectious Zika virus particles;
- and
- (iii) further purifying said Zika virus preparation (b) by one or more size exclusion methods, wherein said one or more size exclusion methods comprise
- (A) sucrose density gradient centrifugation;
- and/or
- (B) a solid-phase matrix packed in a column comprising a ligand-activated core and an inactive shell comprising pores, wherein the pores comprise a molecular weight cut-off that excludes the Zika virus particles from entering the ligand-activated core, and wherein a molecule smaller than the molecular weight cut-off of the pores can enter the ligand-activated core, thereby collecting the Zika virus particles, and/or
- (C) size exclusion chromatography;
- to obtain a final Zika virus preparation (c) comprising infectious Zika virus particles, less than 100 ng/mL residual host cell DNA, less than 1 μg/mL residual host cell protein, and less than 1 μg/mL residual aggregates of Zika virus particles.
6 more elements
Dependencies are inferred from the claim text.